Therefore, it is assumed that aberrant transcriptional activity induced by high expression or mutation of NRF2 may lead to malignancy in combination with other factors (for example, mutation of oncogene leads cells to early cancer state or abnormality of metabolic state changes in cellular environment). This evidence concerns the gene NFE2L2 and cancer.